Clinical trial
Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men…
NCT00004219 · Simbec Research, Industry · Unknown status
Key facts
| NCT number | NCT00004219 |
|---|---|
| Title | Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma |
| Official title | A Study to Investigate the Efficacy and Tolerability of Two Dose Levels of Lerisetron Compared With Granisetron in Patients Receiving Radiotherapy for Stage I Seminoma |
| Lead sponsor | Simbec Research, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Nausea and Vomiting, Testicular Germ Cell Tumor |
| Intervention type | Drug, Radiation |
| Interventions | granisetron hydrochloride, lerisetron, radiation therapy |
| Enrollment | 150 |
| First posted | Aug 9, 2004 |
| Last update posted | Aug 2, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: